T-Neuro Pharma

About

T-NeuroDx, based in Albuquerque, New Mexico, is an innovative healthcare company revolutionizing Alzheimer's disease diagnostics through groundbreaking biomarker research. Operating under the mission of "Diagnosing Alzheimer's Before It's Too Late," the company is commercializing a diagnostic test for hiT cells, a newly discovered biomarker that initiates Alzheimer's pathology. Led by Co-Founder and Chief Science Officer Dr. Christopher Wheeler, T-NeuroDx has pioneered research demonstrating that aged, self-reactive T cells migrate from peripheral blood to the brain early in disease progression, triggering Alzheimer's pathology in animal models. This breakthrough represents the first identified biomarker that initiates Alzheimer's in an animal model, positioning the company at the forefront of early detection technology. Unlike traditional approaches that target visible symptoms, T-NeuroDx focuses on the root cause of disease initiation, offering healthcare providers and patients a more sensitive and earlier detection method. Their innovative diagnostic capabilities address the critical need for early intervention in Alzheimer's treatment, potentially improving patient outcomes through timely diagnosis. Located at Innovation Parkway in Albuquerque's technology corridor, T-NeuroDx combines cutting-edge scientific research with practical diagnostic applications, advancing the future of neurological healthcare through precision medicine and biomarker innovation.